tert-butyl N-[(2S)-1-[[3,3-dimethyl-1-[4-[[4-[[2-[(2R)-3-methyl-2-[2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]propanoylamino]-3-(2-oxo-2-piperidin-1-ylethyl)sulfanylbutanoyl]-3-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3,4-dihydro-1H-isoquinolin-7-yl]carbamoyl]benzoyl]amino]-2-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]-N-methylcarbamate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: tert-butyl N-[(2S)-1-[[3,3-dimethyl-1-[4-[[4-[[2-[(2R)-3-methyl-2-[2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]propanoylamino]-3-(2-oxo-2-piperidin-1-ylethyl)sulfanylbutanoyl]-3-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3,4-dihydro-1H-isoquinolin-7-yl]carbamoyl]benzoyl]amino]-2-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]-N-methylcarbamate
• 化学式: C₇₉H₁₀₇N₁₁O₁₃S
• 分子量: 1450.8
• InChiKey: MLARINCVCJCJPZ-OVRPKQDMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  9.1
• 重原子数：
  104
• 可旋转键数：
  25
• 环数：
  9.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  320
• 氢给体数：
  6
• 氢受体数：
  14

文献信息

• NOVEL IMAGING METHOD
  申请人：Newton Ben

  公开号：US20100316565A1

  公开（公告）日：2010-12-16

  The present invention relates to a method useful in facilitating the identification of fibrogenesis in a subject. The method of the invention is particularly useful when applied as part of a method to diagnose fibrogenesis of the liver. The invention also provides a compound for use in a method for identification of fibrogenesis in a subject A further aspect of the invention is a compound for use in the preparation of a medicament for use in a method for identification of fibrogenesis in a subject.
• [EN] IAP ANTAGONISTS<br/>[FR] ANTAGONISTES D'IAP
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2014047024A1

  公开（公告）日：2014-03-27

  There are disclosed compounds of formula (I) that modulate the activity of inhibitors of apoptosis (lAPs), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention. (Formula (I))